Familial dementia with frontotemporal features associated with M146V presenilin-1 mutation

Brain Pathology

Volumn 23, Issue 5, 2013, Pages 595-600

  Riudavets, Miguel A ^a   Bartoloni, Leonardo ^b   Troncoso, Juan C ^c   Pletnikova, Olga ^c   St George Hyslop, Peter ^d   Schultz, Marcelo ^a   Sevlever, Gustavo ^a   Allegri, Ricardo F ^a  

^a FLENI   (Argentina)

^b Hospital General de Agudos Dr Abel Zubizarreta   (Argentina)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Alzheimer's disease; FTD; M146V; oligodendrocytes; Pick bodies; PS 1 mutations

Indexed keywords

PRESENILIN 1; UBIQUITIN;

ADULT; AMYLOID PLAQUE; ARTICLE; CASE REPORT; CELL NUCLEUS INCLUSION BODY; CLINICAL EVALUATION; CODON; DISEASE ASSOCIATION; FAMILY HISTORY; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; HUMAN; MALE; NEUROPATHOLOGY; OLIGODENDROGLIA; PHENOTYPE; WHITE MATTER;

ALZHEIMER'S DISEASE; FTD; M146V; OLIGODENDROCYTES; PICK BODIES; PS-1 MUTATIONS;

ADULT; DEMENTIA; DNA MUTATIONAL ANALYSIS; ELECTROENCEPHALOGRAPHY; FAMILY HEALTH; FEMALE; FRONTAL LOBE; HUMANS; INCLUSION BODIES; MAGNETIC RESONANCE IMAGING; MALE; METHIONINE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PLAQUE, AMYLOID; PRESENILIN-1; TEMPORAL LOBE; TOMOGRAPHY SCANNERS, X-RAY COMPUTED; VALINE;

EID: 84882266141     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/bpa.12051     Document Type: Article

References (36)

1. Alzheimer A, (1906) Uber einen eigenartigen schweren Krankheitsprozess der Hirnrinde. Neurol Centralbl 25: 1134.
2. Alzheimer's-Association (2009) Alzheimer's disease facts and figures. Alzheimers Dement 5: 1-80.
3. Amtul Z, Lewis PA, Piper S, Crook R, Baker M, Findlay K, et al (2002) A presenilin 1 mutation associated with familial frontotemporal dementia inhibits g-secretase cleavage of APP and notch. Neurobiol Dis 9: 269-273.
4. Braak H, Braak E, (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82: 239-259.
5. Bruni AC, Bernardi L, Colao R, Rubino E, Smirne N, Frangipane F, et al (2010) Worldwide distribution of PSEN1 Met146Leu mutation: a large variability for a founder mutation. Neurology 74: 798-806.
6. Dermaut B, Kumar-Singh S, Engelborghs S, Theuns J, Rademakers R, Saerens J, et al (2004) A novel presenilin 1 mutation associated with Pick's disease but not B-amyloid plaques. Ann Neurol 55: 617-626.
7. Desai MK, Guercio BJ, Narrow WC, Bowers WJ, (2011) An Alzheimer's disease-relevant presenilin-1 mutation augments amyloid-beta-induced oligodendrocyte dysfunction. Glia 59: 627-640.
8. Feng R, Wang H, Wang J, Shrom D, Zeng X, Tsien JZ, (2004) Forebrain degeneration and ventricle enlargement caused by double knockout of Alzheimer's presenilin-1 and presenilin-2. Proc Natl Acad Sci USA 101: 8162-8167.
9. Folstein MF, Folstein SE, McHugh PR, (1975) "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198.
10. Godbolt A, Cipolotti L, Watt H, Fox NC, Janssen JC, Rossor MN, (2004) The natural history of Alzheimer disease: a longitudinal presymptomatic and symptomatic study of a familial cohort. Arch Neurol 61: 1743-1748.
11. Goldbaum O, Richter-Landsberg C, (2004) Proteolytic stress causes heat shock protein induction, tau ubiquitination, and the recruitment of ubiquitin to tau-positive aggregates in oligodendrocytes in culture. J Neurosci 24: 5748-5757.
12. Halliday GM, Song Y, Lepar G, Brooks W, Kwok J, Kersaitis C, et al (2005) Pick bodies in a family with presenilin-1 Alzheimer's disease. Ann Neurol 57: 139-143.
13. Hutton M, (2004) Presenilin mutations associated with fronto-temporal dementia. Ann Neurol 55: 604-606.
14. Ikeda M, Ishikawa T, Tanabe H, (2004) Epidemiology of frontotemporal lobar degeneration. Dement Geriatr Cogn Disord 17: 265-268.
15. Johnson J, Head E, Kim R, Starr A, Cotman C, (1999) Clinical and pathological evidence for a frontal variant of Alzheimer disease. Arch Neurol 56: 1233-1239.
16. Kaplan E, Goodglass H, Weintraub S, (1983) Boston Naming Test. Lea & Febiger: Philadelphia.
17. Lowe J, Mirra S, Hyman BT, Dickson D, (2008) Greenfield's Neuropathology. Hodder Arnold: London.
18. Mirra S, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, et al (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41: 479-486.
19. Murayama S, Arima K, Nakazato Y, Satoh J, Oda M, Inose T, (1992) Immunocytochemical and ultrastructural studies of neuronal and oligodendroglial cytoplasmic inclusions in multiple system atrophy. Oligodendroglial cytoplasmic inclusions. Acta Neuropathol 84: 32-38.
20. Pirici D, Vandenberghe R, Rademakers R, Dermaut B, Cruts M, Vennekens K, et al (2006) Characterization of ubiquitinated intraneuronal inclusions in a novel Belgian frontotemporal lobar degeneration family. J Neuropathol Exp Neurol 65: 289-301.
21. Plassman B, Langa K, Fisher G, Heeringa S, Weir D, Mea O, (2007) Prevalence of dementia in the United States: the aging, demographics, and memory study. Neuroepidemiology 29: 125-132.
22. Pletnikova O, West N, Lee M, Rudow G, Skolasky R, Dawson T, et al (2005) Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases. Neurobiol Aging 26: 1183-1192.
23. Reitan R, (1958) Validity of the trail making test as an indication of organic brain damage. Percept Mot Skills 8: 271-276.
24. Rockenstein E, Ubhi K, Inglis C, Mante M, Patrick C, Adame A, Masliah E, (2012) Neuronal to oligodendroglial α-synuclein redistribution in a double transgenic model of multiple system atrophy. Neuroreport 23: 259-264.
25. Rogaeva E, Bergeron C, Sato C, Moliaka I, Kawarai T, Toulina A, et al (2003) PS1 Alzheimer's disease family with spastic paraplegia: the search for a gene modifier. Neurology 61: 1005-1007.
26. Rogaeva EA, Fafel KC, Song YQ, Medeiros H, Sato C, Liang Y, et al (2001) Screening for PS1 mutations in a referral-based series of AD cases. 21 Novel mutations. Neurology 57: 621-625.
27. Schellenberg GD, Bird TD, Wijsman EM, Orr HT, Anderson L, Nemens E, et al (1992) Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science 258: 668-671.
28. Scholl M, Almkvist O, Bogdanovic N, Wall A, Langstrom B, Viitanen M, Nordberg A, (2011) Time course of glucose metabolism in relation to cognitive performance and postmortem neuropathology in Met146Val PSEN1 mutation carriers. J Alzheimers Dis 24: 495-506.
29. Shepherd C, McCann H, Halliday GM, (2009) Variations in the neuropathology of familial Alzheimer's disease. Acta Neuropathol 118: 37-52.
30. Shepherd CE, Gregory GC, Vickers JC, Brooks WS, Kwok JB, Schofield PR, et al (2004) Positional effects of presenilin-1 mutations on tau phosphorylation in cortical plaques. Neurobiol Dis 15: 115-119.
31. Signoret J, Whiteley A, (1979) A memory battery scale. Int Neuropsychol Soc Bull 9: 2-26.
32. St George-Hyslop P, Haines J, Rogaev E, Mortilla M, Vaula G, Pericak-Vance M, et al (1992) Genetic evidence for a novel familial Alzheimer's disease locus on chromosome 14. Nat Genet 2: 330-334.
33. St George-Hyslop PH, Tanzi RE, Polinsky RJ, Haines JL, Nee L, Watkins PC, et al (1987) The genetic defect causing familial Alzheimer's disease maps on chromosome 21. Science 235: 885-890.
34. Wechsler D, (1981) WAIS-R Manual: Wechsler Adult Intelligence Scale-Revised. Psychological Corporation: New York.
35. Wilson C, Murphy D, Giasson B, Zhang B, Trojanowski J, Lee V, (2004) Degradative organelles containing mislocalized alpha-and beta-synuclein proliferate in presenilin-1 null neurons. J Cell Biol 165: 335-346.
36. Woodward M, Jacova C, Black S, Kertesz A, Mackenzie I, Feldman H, (2009) Differentiating the frontal variant of Alzheimer's disease. Int J Geriatr Psychiatry 25: 732-738.